Nuveen’s SBC Medical Group SBC Stock Holding History

Nuveen’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$51.7K	Hold	12,368	–	–	﹤0.01%	3204
2025 Q4	$53.3K	Buy	+12,368	New	+$47.2K	﹤0.01%	3236

Other funds holding SBC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nuveen's SBC Position: Q1 2026 in Review

Nuveen held its SBC Medical Group (SBC) position steady in Q1 2026 at 12,368 shares worth $51.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3204.

Nuveen first reported a position in SBC in Q4 2025 and has held it in 2 quarters since. The position peaked at $53.3K in Q4 2025. 50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.

Nuveen held 12,368 shares of SBC Medical Group worth $51.7K as of Q1 2026.
Nuveen left its SBC Medical Group share count unchanged in Q1 2026.
SBC Medical Group made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #3204 holding.
Nuveen first reported a position in SBC Medical Group in Q4 2025 and has held it in 2 quarters since.
Nuveen's SBC Medical Group position peaked at $53.3K in Q4 2025.
50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.